Holen Sie sich die Stockscreener-App
2.12
0.95%
0.02
Handel nachbörslich:
2.10
-0.02
-0.94%
Schlusskurs vom Vortag:
$2.10
Offen:
$2.1
24-Stunden-Volumen:
1.58M
Relative Volume:
0.80
Marktkapitalisierung:
$300.08M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-35.47M
KGV:
-3.7193
EPS:
-0.57
Netto-Cashflow:
$-124.27M
1W Leistung:
-8.62%
1M Leistung:
-33.75%
6M Leistung:
+198.34%
1J Leistung:
+12.77%
1-Tages-Spanne:
$2.04
$2.15
1-Wochen-Bereich:
$2.04
$2.4693
52-Wochen-Spanne:
$0.4603
$7.13
Prokidney Corp Stock (PROK) Company Profile
Firmenname
Prokidney Corp
Sektor
Branche
Telefon
336-999-7028
Adresse
2000 FRONTIS PLAZA BLVD., WINSTON-SALEM
Vergleichen Sie PROK mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PROK
Prokidney Corp
|
2.12 | 297.25M | 0 | -35.47M | -124.27M | -0.57 |
|
VRTX
Vertex Pharmaceuticals Inc
|
432.17 | 109.05B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
784.61 | 82.75B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
445.12 | 56.78B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
917.63 | 56.52B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
204.51 | 44.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Prokidney Corp Stock (PROK) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-30 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2024-09-30 | Eingeleitet | JP Morgan | Neutral |
| 2024-09-10 | Eingeleitet | Guggenheim | Buy |
| 2024-03-07 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2024-01-02 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-07-25 | Eingeleitet | BTIG Research | Buy |
| 2022-12-21 | Eingeleitet | Jefferies | Buy |
| 2022-11-10 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2022-10-18 | Eingeleitet | UBS | Buy |
| 2022-10-14 | Eingeleitet | Citigroup | Buy |
| 2022-09-23 | Eingeleitet | BofA Securities | Buy |
| 2022-09-02 | Eingeleitet | Evercore ISI | Outperform |
Alle ansehen
Prokidney Corp Aktie (PROK) Neueste Nachrichten
ProKidney site sells Greensboro site for $6.5M less than it paid for property - The Business Journals
While insiders own 18% of ProKidney Corp. (NASDAQ:PROK), retail investors are its largest shareholders with 50% ownership - Yahoo Finance
ProKidney Corp. (PROK) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
How ProKidney Corp. stock benefits from tech adoptionWeekly Volume Report & Smart Money Movement Alerts - newser.com
Will ProKidney Corp. stock beat EPS estimatesMarket Rally & Free Risk Controlled Daily Trade Plans - newser.com
What data driven models say about ProKidney Corp.’s futureQuarterly Market Summary & Weekly Stock Breakout Alerts - newser.com
What technical charts say about ProKidney Corp. stockJuly 2025 Levels & Low Drawdown Momentum Ideas - newser.com
What valuation multiples suggest for ProKidney Corp. stockJuly 2025 EndofMonth & Reliable Trade Execution Plans - newser.com
Is now a turning point for ProKidney Corp.Recession Risk & Fast Entry Momentum Trade Alerts - newser.com
What sentiment indicators say about ProKidney Corp. stock2025 Breakouts & Breakdowns & Free Expert Approved Momentum Trade Ideas - newser.com
[EFFECT] PROKIDNEY CORP. SEC Filing - Stock Titan
Automated trading signals detected on ProKidney Corp.Market Volume Summary & Fast Exit/Entry Strategy Plans - newser.com
Will ProKidney Corp. stock recover faster than peersDollar Strength & AI Enhanced Trading Alerts - newser.com
Greensboro ProKidney site sells for $19.1M - Winston-Salem Journal
What to expect from ProKidney Corp. in the next 30 daysQuarterly Investment Review & Daily Growth Stock Tips - newser.com
ProKidney Corp. (NASDAQ:PROK) Receives Average Rating of "Hold" from Analysts - MarketBeat
Brian Jg Pereira Sells 255,026 Shares of ProKidney (NASDAQ:PROK) Stock - MarketBeat
Insider Selling: ProKidney (NASDAQ:PROK) Director Sells 502,136 Shares of Stock - MarketBeat
Will ProKidney Corp. stock go up soonWeekly Gains Summary & Breakout Confirmation Trade Signals - newser.com
What candlestick patterns are forming on ProKidney Corp.2025 Historical Comparison & Stepwise Trade Signal Implementation - newser.com
Is ProKidney Corp. stock poised for growthJuly 2025 Spike Watch & Reliable Price Action Trade Plans - newser.com
ProKidney Independent Director Brian Jude Pereira Sells 100% Of Holding - simplywall.st
Visual analytics tools that track ProKidney Corp. performance2025 Retail Activity & AI Driven Price Forecasts - newser.com
Heatmap analysis for ProKidney Corp. and competitorsInflation Watch & Risk Adjusted Swing Trade Ideas - newser.com
How ProKidney Corp. stock performs in stagflationMarket Risk Analysis & High Accuracy Swing Entry Alerts - newser.com
ProKidney (NASDAQ:PROK) Shares Down 14.4%Time to Sell? - MarketBeat
Dir Pereira Sells 757,162 ($1.9M) Of ProKidney Corp [PROK] - TradingView
Tangible book value per share of ProKidney Corp. Class A – BMV:PROK - TradingView
Published on: 2025-11-13 04:33:50 - newser.com
Dir Pereira Files To Sell 675,234 Of ProKidney Corp [PROK] - TradingView
ProKidney’s Autologous Cell Therapy for CKD and Diabetes Advances to Phase III - Inside Precision Medicine
ProKidney at Guggenheim Conference: Strategic Advances in Kidney Treatment By Investing.com - Investing.com Nigeria
Finanzdaten der Prokidney Corp-Aktie (PROK)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.76%
2.16%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):